Ipsen[Grants and Funding] - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Ipsen[Grants and Funding] - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2018	4
2019	8
2020	16
2021	21
2022	16
2023	25
2024	15

92 results

Page of 10

Results by year

Page 1

Optimal follow-up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours.

Ohlsson H, Spaak E, Gålne A, Sundlöv A, Almquist M. Ohlsson H, et al. J Neuroendocrinol. 2024 Apr 28:e13396. doi: 10.1111/jne.13396. Online ahead of print. J Neuroendocrinol. 2024. PMID: 38679928

Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016.

Orme S, McNally R, James PW, Davis J, Ayuk J, Higham C, Wass J; UK Acromegaly Register Study Group. Orme S, et al. Clin Endocrinol (Oxf). 2024 Jun;100(6):558-564. doi: 10.1111/cen.15060. Epub 2024 Apr 23. Clin Endocrinol (Oxf). 2024. PMID: 38652736

Acute Effects of Testosterone on Whole-Body Protein Metabolism in Hypogonadal and Eugonadal Conditions: A Randomized, Placebo-Controlled, Crossover Study.

Ornstrup MJ, Høst C, Rittig N, Gravholt CH. Ornstrup MJ, et al. J Appl Physiol (1985). 2024 Apr 18. doi: 10.1152/japplphysiol.00078.2024. Online ahead of print. J Appl Physiol (1985). 2024. PMID: 38634506

Dosimetry and pharmacokinetics of [¹⁷⁷Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.

Schürrle SB, Eberlein U, Ansquer C, Beauregard JM, Durand-Gasselin L, Grønbæk H, Haug A, Hicks RJ, Lenzo NP, Navalkissoor S, Nicolas GP, Pais B, Volteau M, Wild D, McEwan A, Lassmann M. Schürrle SB, et al. Eur J Nucl Med Mol Imaging. 2024 Mar 26. doi: 10.1007/s00259-024-06682-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38528164

Girls with idiopathic central precocious puberty did not display substatial changes in body mass index after treatment with gonadotropin-releasing hormone analogues.

Uldbjerg CS, Lim YH, Renault CH, Hansen D, Juul A, Bräuner EV, Jensen RB. Uldbjerg CS, et al. Acta Paediatr. 2024 Mar 20. doi: 10.1111/apa.17185. Online ahead of print. Acta Paediatr. 2024. PMID: 38506052

Neuroendocrine neoplasms: Consensus on a patient care pathway.

Hooper J, Jervis N, Morgan L, Beckett V, Hand P, Higgs K, Munir A, Prinn J, Pritchard DM, Sarker D, Srirajaskanthan R, Ellis CB. Hooper J, et al. J Neuroendocrinol. 2024 Apr;36(4):e13380. doi: 10.1111/jne.13380. Epub 2024 Mar 12. J Neuroendocrinol. 2024. PMID: 38471798 Review.

Spatiotemporal Gait Differences before and after Botulinum Toxin in People with Focal Dystonia: A Pilot Study.

Cuinat J, Debû B, Meoni S, Pelissier P, Castrioto A, Fraix V, Moro E. Cuinat J, et al. Mov Disord Clin Pract. 2024 Feb;11(2):143-151. doi: 10.1002/mdc3.13944. Epub 2023 Dec 14. Mov Disord Clin Pract. 2024. PMID: 38386480

A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling.

Ibrahim H, Retailleau K, Hornby F, Maignel J, Beard M, Daly DM. Ibrahim H, et al. Toxins (Basel). 2024 Jan 7;16(1):30. doi: 10.3390/toxins16010030. Toxins (Basel). 2024. PMID: 38251246 Free PMC article.

Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.

Pavel M, Lahner H, Hörsch D, Rinke A, Denecke T, Koch A, Regnault B, Helbig D, Hoffmanns P, Raderer M. Pavel M, et al. Oncologist. 2024 May 3;29(5):e643-e654. doi: 10.1093/oncolo/oyad325. Oncologist. 2024. PMID: 38206830 Free PMC article. Clinical Trial.

High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.

Isand K, Feelders R, Brue T, Toth M, Deutschbein T, Reincke M, Kršek M, Santos A, Demtröder F, Chabre O, Strasburger CJ, Aulinas Maso A, Volke V, Pereira AM, Lohmann R, Gich Saladich I; Ercusyn Study Group; Webb SM, Wass J, Valassi E. Isand K, et al. Eur J Endocrinol. 2024 Jan 3;190(1):75-85. doi: 10.1093/ejendo/lvad176. Eur J Endocrinol. 2024. PMID: 38146835

92 results

Page of 10

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year